Kliniska studier för Migrän i North Carolina
12 studier för Migrän söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
Study of EVO756 in Adults With Migraine
- Asheville Neurology Specialists, Pa, Asheville
- Eximia Research NC, Raleigh
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Accellacare - Piedmont, Statesville
- Accellacare of Piedmont HealthCare, Statesville
- Accellacare US Inc., Winston-Salem
RekryterarFas 1
Ålder 6 till 11 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- OnSite Clinical Solutions, LLC, Charlotte
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- OnSite Clinical Solutions, LLC, Charlotte
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Onsite Clinical Solutions Park Cedar Dr., Charlotte
- Onsite Clinical Solutions Mecklenburg, Charlotte
- Onsite Clinical Solutions Ballantyne, Charlotte
- och 2 fler
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 16 sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Queen City Clinical Research, PLLC, Charlotte
Rekryterar
Ålder 22 till 84 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- OnSite Clinical Solutions, Charlotte
- Guildford Neurologic Research Partners, LLC, Greensboro
- Headache Wellness Center, Greensboro
- och 2 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Wake Forest University Health Sciences, Winston-Salem
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 12 juni 2026 · NCT05987592Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Evidera, a PPD business unit, Wilmington
RekryterarObservationsstudie
Ålder 0 och äldre · Kvinnor · Uppdaterad 5 maj 2026 · NCT05046613Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Iqvia /Id# 266904, Durham
RekryterarObservationsstudie
Ålder 18 och äldre · Kvinnor · Uppdaterad 15 dec. 2025 · NCT05158894Aimovig Pregnancy Exposure Registry
- IQVIA Virtual Site, Durham
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 99 · Kvinnor · Uppdaterad 4 nov. 2025 · NCT06150781Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.